Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis

MLA

Liu, Jianyang, et al. “Urinary Prostanoids Are Elevated by Anti-TNF and Anti-IL6 Receptor Disease-Modifying Antirheumatic Drugs but Are Not Predictive of Response to Treatment in Early Rheumatoid Arthritis.” Arthritis Research & Therapy (Formerly Arthritis Research), vol. 26, no. 1, Dec. 2024. EBSCOhost, https://doi.org/10.1186/s13075-024-03295-9.

APA

Liu, J., Idborg, H., Korotkova, M., Lend, K., van Vollenhoven, R., Lampa, J., Rudin, A., Nordström, D., Gudbjornsson, B., Gröndal, G., Uhlig, T., Hørslev-Petersen, K., Lund Hetland, M., Østergaard, M., Nurmohamed, M., & Jakobsson, P.-J. (2024). Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis. Arthritis Research & Therapy (Formerly Arthritis Research), 26(1). https://doi.org/10.1186/s13075-024-03295-9

Chicago

Liu, Jianyang, Helena Idborg, Marina Korotkova, Kristina Lend, Ronald van Vollenhoven, Jon Lampa, Anna Rudin, et al. 2024. “Urinary Prostanoids Are Elevated by Anti-TNF and Anti-IL6 Receptor Disease-Modifying Antirheumatic Drugs but Are Not Predictive of Response to Treatment in Early Rheumatoid Arthritis.” Arthritis Research & Therapy (Formerly Arthritis Research) 26 (1). doi:10.1186/s13075-024-03295-9.